MedTrace Logo

Assessment of Maternal and Fetal Serum Biomarkers in Women With Pre-eclampsia

NCT06712550 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 204

Last updated 2025-07-16

No results posted yet for this study

Summary

The findings of markers of placental dysfunction in women with preeclampsia may suggest that these biomarkers may be useful tools for early detection of preeclampsia

Conditions

  • Inflammatory Markers
  • Preeclampsia Severe
  • Preeclampsia Mild
  • Umbilical Cord Issue
  • Inflammatory Response
  • Serum Seromucoid in Pregnancy
  • Protein-bound Hexose in Preeclampsia

Sponsors & Collaborators

  • SHAHLA KAREEM ALALAF

    lead OTHER

Principal Investigators

  • SHAHLA K. ALALAF, prof. · Hawler Medical University

  • Jiyan L. Hussein, Assis. prof · Salahadin University, College of Science

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-13
Primary Completion
2025-07-03
Completion
2025-07-12

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06712550 on ClinicalTrials.gov